Skip to main content
. 2018 Jan 24;154(3):273–280. doi: 10.1001/jamadermatol.2017.5757

Figure 1. Statistical Trends in Device Approvals and Supplement Use.

Figure 1.

A, Original Class III device approval rates show no observable trend over the study period (January 1980-November 2016). B, Supplement use during the same period has statistically significantly increased, with a stronger observable trend over the past decade. PMA indicates premarket approval.